The World Health Organization on Wednesday said a clinical trial in 52 countries will study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
“These therapies - artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized COVID-19 patients,” it said in a statement.
Artesunate is already used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis.
COVID-19 anti-vaxxers can derail fight against pandemic: UAE health expertsAnti-vaxxers could hinder the fight to achieve herd immunity against COVID-19 while putting others at risk, health experts in the United Arab Emirates ... Coronavirus
UAE records lowest daily number of new COVID-19 cases in three monthsThe United Arab Emirates has recorded 1,321 new cases of COVID-19 and three virus-related deaths in the last 24 hours, the country’s National Crisis ... Coronavirus
Coronavirus: The top conspiracy theories surrounding COVID-19Since the coronavirus first emerged, the prolonged pandemic has lent itself to endless headlines about the virus; from its rampant spread across the ... Coronavirus